Aethlon Medical, Inc. (AEMD) vs Cadrenal Therapeutics, Inc. Common Stock (CVKD)
A side-by-side comparison of Aethlon Medical, Inc. and Cadrenal Therapeutics, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AEMD
Aethlon Medical, Inc.
$6.35HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
CVKD
Cadrenal Therapeutics, Inc. Common Stock
$0.95HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — AEMD vs CVKD
growth of $100 · dividends reinvested · last 4yAEMD -99.6% (-75.5%/yr)CVKD -98.5% (-64.8%/yr)CVKD compounded faster over this window
AEMD CVKD
AEMD vs CVKD: by the numbers
- •CVKD is the larger company ($3M vs $3M market cap).
Metrics side by side
Valuation
| Metric | AEMD | CVKD |
|---|---|---|
| P/B ratio | 0.64 | 0.82 |
Profitability
| Metric | AEMD | CVKD |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -133.43% | -282.13% |
| ROIC | -133.29% | -284.81% |
Growth (annualized)
| Metric | AEMD | CVKD |
|---|---|---|
| Total return CAGR (5Y) | -78.27% | N/A |
Go deeper
Dig into the metrics
Aethlon Medical ROECadrenal Therapeutics, Inc. Common Stock ROEAethlon Medical operating marginCadrenal Therapeutics, Inc. Common Stock operating marginAethlon Medical revenue growthCadrenal Therapeutics, Inc. Common Stock revenue growthAethlon Medical free cash flowCadrenal Therapeutics, Inc. Common Stock free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.